Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Five-year heart study for Imatron (US):

This article was originally published in Clinica

Executive Summary

Imatron (US) and the University of Washington are collaborating in a new study of heart disease patients using Imatron's HeartScan coronary artery CT system to determine the degree of coronary artery calcification. The first of 160 patients with coronary artery disease and low HDL levels have undergone baseline coronary artery scans at Imatron's HeartScan-Seattle Coronary Artery Disease Risk Assessment Center. Serial scan findings will be compared with clinical and angiographic findings. Patients are to be assigned to three treatment groups, in the five-year double-blind study, to assess the magnitude and mechanism of beneficial drugs and vitamins on coronary artery disease.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093705

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel